FDA Announces Resolution of IV Saline Solutions Shortage
By Stephanie Brown HealthDay Reporter
Medically reviewed by Drugs.com
WEDNESDAY, Aug. 13, 2025 -- The nationwide shortage of sodium chloride 0.9 percent intravenous (IV) saline has officially ended, according to the U.S. Food and Drug Administration.
FDA Commissioner Marty Makary, M.D., M.P.H., stated that the shortage has ended due to the combined efforts of the FDA, Administration for Strategic Preparedness and Response, and industry partners. The teams worked together to quickly boost manufacturing and stabilize the supply chain by enabling temporary IV solution imports, expediting manufacturing reviews, and extending product expiry dates.
The sodium chloride 0.9 percent injection shortage is resolved, and it will be removed from the FDA Drug Shortage Database; facilities are advised to use FDA-approved products when available. The FDA is continuing efforts with manufacturers to address other IV fluid shortages and is prioritizing reliable medical product availability.
"The FDA remains focused on doing all we can to help mitigate shortages and prevent them from occurring," Makary said in a statement. "We will continue working diligently to monitor supply levels, anticipate potential disruptions, and support a robust, secure, and transparent supply chain for medical products."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2025
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.